Sufentanil sublingual tablet system. From rationale of use to clinical practice

Autor:	A, Vergari, A, Cortegiani, M, Rispoli, F, Coluzzi, F, Deni, Y, Leykin, F, Luca Lorini, P P, Martorano, A, Paolicchi, E, Polati, M, Scardino, A, Corcione, A, Giarratano, M, Rossi
Přispěvatelé:	Vergari, A, Cortegiani, A, Rispoli, M, Coluzzi, F, Deni, F, Leykin, Y, Luca Lorini, F, Martorano, P P, Paolicchi, A, Polati, E, Scardino, M, Corcione, A, Giarratano, A, Rossi, M
Jazyk:	angličtina
Rok vydání:	2020
Předmět:	Pain Postoperative Administration Sublingual Analgesia Patient-Controlled Clinical practice Neuropathic pain Acute Pain SST Analgesics Opioid SSTS sufentanil clinical practice neuropathic pain surgery Practice Guidelines as Topic Humans Pain Management Surgery Tablets
Popis:	The control of post-operative pain in Italy and other western countries is still suboptimal. In recent years, the Sufentanil Sublingual Tablet System (SSTS; Zalviso; AcelRx Pharmaceuticals, Redwood City, CA, USA), which is designed for patient-controlled analgesia (PCA), has entered clinical practice. SSTS enables patients to manage moderate-to-severe acute pain during the first 72 postoperative hours directly in the hospital setting. However, the role of SSTS within the current framework of options for the management of post-operative pain needs to be better established. This paper presents the position on the use of SSTS of a multidisciplinary group of Italian Experts and provides protocols for the use of this device.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::7f156f50e5c9c9a17ad870d094e2b5b1 http://hdl.handle.net/11573/1479871 Zobrazit plný text záznamu